PharmaHub · Other Pharma & Biotech · Asia Pacific

India Single Use Bioprocessing Probes Sensors Market Report: Market Size & Forecast 2026

The India Single-Use Bioprocessing Probes and Sensors market is a critical segment of the Asia Pacific bioprocessing industry, valued at approximately $24.62 billion in 2025 and expanding at a compound annual growth rate of 13.3%. These single-use sensors, including pH, dissolved oxygen, temperature, pressure, conductivity, and flow sensors, are designed for one-time use in biopharmaceutical manufacturing, eliminating the need for costly cleaning and sterilization cycles required by traditional reusable stainless-steel systems. The market is propelled by India's rapidly growing pharmaceutical and biotechnology sectors, the increasing adoption of single-use technologies to reduce operational costs, and supportive government initiatives such as the Production Linked Incentive scheme that are accelerating domestic biopharmaceutical production capacity across the country.

Market size · 2025
$24.6 billion
CAGR · 2025–2030
13.3%
Forecast · 2030
$46 billion
Basis
Claight Analysis
Market size (USD)
Base year 2025
Official data · Claight AnalysisForecast
Market size and forecast are Claight Analysis, informed by public research.
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2025 base: $24.6bn2030 est: $46bn
Read the full India Single Use Bioprocessing Probes Sensors Market Report report →

Market Overview

Single-use bioprocessing probes and sensors are disposable measurement devices used throughout the biopharmaceutical manufacturing process, particularly in bioreactors, mixers, and filtration systems. Unlike traditional reusable stainless-steel probes that require extensive cleaning-in-place and sterilization-in-place protocols, single-use sensors are pre-sterilized, gamma-irradiated, and designed for a single production batch, dramatically reducing cross-contamination risks and operational downtime. The India single-use bioprocessing probes and sensors market generated revenues of approximately $93.4 million in 2023 and is on a trajectory to reach roughly $260 million by 2030, reflecting the country's accelerating shift toward flexible and cost-efficient biomanufacturing platforms. This segment forms an integral part of the broader India single-use bioprocessing market, which reached approximately $31.23 billion in 2025.

  • India's single-use bioprocessing probes and sensors market is projected to grow from approximately $93.4 million in 2023 to roughly $260 million by 2030, driven by the domestic biopharmaceutical industry's expansion
  • The broader single-use bioprocessing market in India is valued at approximately $31.23 billion in 2025, with the Asia Pacific region's single-use bioprocessing market reaching $24.62 billion in the same year
  • Single-use sensors eliminate the need for cleaning-in-place and sterilization-in-place cycles, significantly reducing operational costs, turnaround time, and cross-contamination risks in biologics manufacturing

Growth Drivers

India's pharmaceutical industry, the world's third-largest by volume, is undergoing a structural transformation toward high-value biologics manufacturing, including monoclonal antibodies, vaccines, and cell and gene therapies, all of which demand precise real-time monitoring through advanced sensors. The cost competitiveness of single-use systems relative to stainless-steel infrastructure is particularly compelling for contract development and manufacturing organizations and emerging biotech firms with limited capital expenditure budgets. Additionally, India's biotechnology sector has benefited from substantial government support through the National Biotechnology Development Strategy and PLI schemes for biologics and bulk drugs, creating a favorable environment for the adoption of modern bioprocessing technologies.

  • India's biologics and biosimilars pipeline is expanding rapidly, with the country emerging as a global hub for contract manufacturing, driving demand for disposable monitoring and control systems
  • Single-use bioprocessing reduces capital expenditure by eliminating the need for fixed stainless-steel infrastructure and associated cleaning validation, making it especially attractive for small-to-mid-scale manufacturers
  • Regulatory acceptance of single-use technologies by global health authorities, including the WHO and various national drug regulators, has accelerated their integration into GMP-compliant manufacturing processes in India
Want a deeper cut on India Single Use Bioprocessing Probes Sensors Market Report? We build bespoke studies on request.
Connect to an analyst →

Segmentation and Regional Analysis

The market is segmented by sensor type into pH sensors, dissolved oxygen sensors, pressure sensors, temperature sensors, conductivity sensors, flow meters and sensors, and others, with pH and dissolved oxygen sensors commanding the largest market share due to their critical role in monitoring cell culture conditions. By workflow, the upstream processing segment dominates as single-use bioreactors for cell culture represent the highest-volume application area for probes and sensors. Geographically, while India is a key growth market, the broader Asia Pacific single-use bioprocessing market reached $24.62 billion in 2025, fueled by robust pharmaceutical manufacturing sectors across China, India, South Korea, and Singapore.

  • pH sensors, dissolved oxygen sensors, and temperature sensors collectively account for the largest share of the single-use probes and sensors market, as these parameters are critical for optimizing cell growth and product yield
  • Upstream bioprocessing, encompassing cell culture and fermentation within single-use bioreactors, represents the dominant application segment, supported by the rising number of biologics production facilities across India
  • Western and southern India, home to major pharmaceutical clusters in Maharashtra, Telangana, and Karnataka, account for a disproportionate share of single-use bioprocessing equipment demand

Trends and Outlook

What are the recent trends and outlook?

The integration of single-use sensors with advanced process analytical technologies and digital manufacturing platforms is emerging as a key trend, enabling real-time data collection, predictive maintenance, and compliance with Process Analytical Technology guidelines. The growing emphasis on personalized medicine, cell therapies, and mRNA-based therapeutics is creating new demand for highly specialized single-use sensing solutions capable of operating in novel manufacturing formats. Over the forecast horizon, the India single-use bioprocessing probes and sensors market is expected to sustain strong double-digit growth as domestic manufacturing capacity expands, global pharmaceutical companies deepen their India footprints, and the country's biosimilars and vaccine production ambitions continue to scale.

  • The convergence of single-use sensors with Industry 4.0 technologies, including cloud-based data analytics and real-time process monitoring dashboards, is enhancing manufacturing efficiency and regulatory compliance across Indian biopharmaceutical facilities
  • The global single-use bioprocessing probes and sensors market is expected to grow from $3.54 billion in 2024 to approximately $9.55 billion by 2032, with India representing one of the fastest-growing regional markets within this trajectory
  • Rising investment in cell and gene therapy manufacturing capabilities in India is driving demand for next-generation single-use sensors capable of supporting complex, high-precision bioprocesses including perfusion culture and continuous manufacturing
Talk to a Claight analyst
Do you want to research India Single Use Bioprocessing Probes Sensors Market Report?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.